Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Nature Medicine

Real-time brain stimulation slashes Parkinson's symptoms by half in trial

A new device reacts to rising and falling levels of Parkinson's medication in the body and improves quality of life for some patients.

LiveScience

Long COVID is still a problem, racking up a global cost of $1 trillion

Experts want government agencies to act.

Fortune

The FDA and psychedelic research

To move the drugs forward, manufacturers may need to follow the agency’s advice for elevating evidence quality

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

New treatment for spinal cord injuries could have ‘profound benefit’, medics say

The Up-LIFT study, which was published in the journal Nature Medicine, was run by ONWARD Medical and involved medical teams around the world.

The Independent UK

New Study Reveals Inherited Risk For Alzheimer's Disease

New research in Nature Medicine highlights APOE gene's role in Alzheimer's inheritance and risk. Understanding genetic basis crucial for diagnosis and trea...

Top News

Designer immune-cell therapy could shrink deadly brain tumors, early trials show

Two early clinical trials that together included nine patients suggest that a treatment called CAR-T therapy could treat glioblastoma, but its long-term effects are unknown.

LiveScience

Significant risk found even in primary dengue infection, says study

Dengue infection: New study challenges belief that severe dengue is mainly due to secondary infections, highlighting importance of primary infections.

The Hindu

Read news from The Economist, FT, and more,
with one subscription

Long COVID. Shorter Life? New research reveals an arduous road to recovery

The first study to look at two years of data shows the devastating effects of long COVID-but there are still no validated treatments.

Fortune

"Journalists Should Be Skeptical of All Sources—Including Scientists"

From Nate Silver: Here's the scandal. In March 2020, a group of scientists — in particular, Kristian G. Andersen the of The Scripps Research Institute, Andrew Rambaut of The University of Edinburgh, Edward C. Holmes of the University of Sydney, and Robert F. Garry of Tulane University — published a…

Reason

Be Skeptical of the New Artificial Sweetener Scare

Plus: Liberal teens are more depressed than conservative ones, the outsize role of immigrants in U.S. innovation, and more...

Reason

Is There A Cure For HIV? Here's What The Treatment Actually Does

A bone marrow transplant isn't an option for everyone with HIV.

Inverse

Patients Should Be Allowed To Choose Their Type 2 Diabetes Medication: Study

During the study, researchers monitored the effect of each drug on the 448 patients' glucose levels, weight and recorded the side effects.Read on for details:

Dynamite News

Even mild COVID raises the chance of heart attack and stroke. What to know about the risks ahead

A concerning report recently published in Nature Medicine suggests even a mild case of COVID can increase the long-term risks of serious cardiovascular diseases such as stroke, heart attack and heart failure. The study highlights our limited understanding of the full consequences of COVID infection and the long-term impact of…

The Conversation

Recap Of Monday's Biotech Catalysts - End Of the Day Summary

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Wales Online

Monkeypox virus mutating quickly warn experts as symptoms change

The findings come from two separate studies with both comparing today's cases with those from the past

The Hindu

Brain networks and nicotine addiction

A study of patients who quit smoking spontaneously reveals brain networks that are associated with alcohol and other forms of addiction

The Independent UK

Long COVID affects more older adults; shots don't prevent it

Research in U.S. veterans provides fresh evidence that long COVID-19 can happen even after breakthrough infections following vaccination

The Independent UK

Could psilocybin mushrooms help with depression?

A small study suggests that psilocybin could increase brain activity in people with depression, writes Andrew Jacobs

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Magic Mushrooms Are More Effective Than Antidepressants In Treating Depression, New Study Shows

A recent study led by Imperial College London’s Centre for Psychedelic Research found that psilocybin could increase neuroplasticity in cases of treatment-resistant depression (TRD), even more than traditional antidepressants, such as selective serotonin reuptake inhibitors (SSRIs). The results of the study were reported in the journal Nature Medicine under the name…

Benzinga

Is Wall Street The Next Stop For Psychedelics? Investing In The Psychedelic Medicine Sector

This article was originally published on Psychedelic Spotlight and appears here with permission. Elemental Advisors Inc. CEO Tim Collins paints a picture of the past, present, and future of the psychedelics market in this guest blog for Psychedelic Spotlight. The use of psychedelic drugs to treat mental health conditions is…

Daily Mirror

Warning issued for Covid sufferers as link to 20 dangerous conditions found in new study

Research published in Nature Medicine shows that anyone who has tested positive for Covid could be at a higher risk of 20 conditions, including a stroke, heart failure and cardiac arrest

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the University of Edinburgh

114 stories

the University of Sydney

US Food and Drug Administration

63 stories

UCSF

43 stories

Psychedelic Spotlight

29 stories

STAT

24 stories

Medicines and Healthcare products Regulatory Agency

23 stories

Tulane University

22 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.